Cavotec: So far so good, but not done yet - ABG

Report out 25 April at 07.00 CEST
Q1e sales of EUR 45m +4% y-o-y, EBIT EUR 3.1m (2m)
12x-8x '25e-'27e EV/EBIT


Q1 expectations

We expect Cavotec to deliver Q1 sales of EUR 45m, +4% y-o-y and -2% q-o-q. Q4'24 order intake was exceptionally strong for Cavotec, due to several large orders (+52% y-o-y including announced orders, +8% y-o-y excluding). However, we do not fully extrapolate this to Q1e, as order intake tends to fluctuate between quarters and no orders were announced during the quarter. Furthermore, we still expect order intake to grow: we estimate EUR 43m, +7% y-o-y. The company continues to work on its change programme with enhanced cost control, which we expect will yield higher margins y-o-y. For EBIT, we forecast EUR 3.1m for a margin of 6.9% (4.5% in Q1'24).

Länk till analysen i sin helhet: https://cr.abgsc.com/foretag/cavotec/Equity-research/2025/4/cavotec---so-far-so-good-but-not-done-yet/